Design Therapeutics Funding: $170M Raised, Series B (2021)
Design Therapeutics is based in Carlsbad. It has raised $170M in total funding. Latest round: Series B.
Design Therapeutics funding overview
Design Therapeutics is based in Carlsbad. Design Therapeutics has raised $170M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for Design Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Logos Capital, Cormorant Asset Management, SR One, Quan Capital, WestRiver Group, BlackRock and 7 others. 13 distinct backers are named across the disclosed rounds.
Design Therapeutics at a glance
Total raised
$170M
Latest round
Series B
Latest round date
January 2021
Headquarters
Carlsbad
Notable investors
Logos Capital, Cormorant Asset Management, SR One, Quan Capital, WestRiver Group, BlackRock, Janus Henderson Investors, RA Capital Management
Frequently asked about Design Therapeutics funding
How much has Design Therapeutics raised?
Design Therapeutics has raised $170M in total disclosed funding across the rounds on record.
Who has invested in Design Therapeutics?
Logos Capital, Cormorant Asset Management, SR One, Quan Capital, WestRiver Group, BlackRock are named among the investors backing Design Therapeutics.
What was the latest Design Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2021.
Where is Design Therapeutics based?
Design Therapeutics is based in Carlsbad.
When did Design Therapeutics last raise?
The last disclosed Design Therapeutics round closed in January 2021 at Series B.
Design Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Carlsbad below to benchmark round size and investor mix.
